EP1254132A4 - Food product and process - Google Patents

Food product and process

Info

Publication number
EP1254132A4
EP1254132A4 EP01901059A EP01901059A EP1254132A4 EP 1254132 A4 EP1254132 A4 EP 1254132A4 EP 01901059 A EP01901059 A EP 01901059A EP 01901059 A EP01901059 A EP 01901059A EP 1254132 A4 EP1254132 A4 EP 1254132A4
Authority
EP
European Patent Office
Prior art keywords
food product
food
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01901059A
Other languages
German (de)
French (fr)
Other versions
EP1254132A1 (en
Inventor
Alan James Husband
Graham Edmund Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kazia Research Pty Ltd
Original Assignee
Novogen Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Research Pty Ltd filed Critical Novogen Research Pty Ltd
Publication of EP1254132A1 publication Critical patent/EP1254132A1/en
Publication of EP1254132A4 publication Critical patent/EP1254132A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/40—Separation, e.g. from natural material; Purification
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
EP01901059A 2000-01-21 2001-01-22 Food product and process Withdrawn EP1254132A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ5203A AUPQ520300A0 (en) 2000-01-21 2000-01-21 Food product and process
AUPQ520300 2000-01-21
PCT/AU2001/000057 WO2001053285A1 (en) 2000-01-21 2001-01-22 Food product and process

Publications (2)

Publication Number Publication Date
EP1254132A1 EP1254132A1 (en) 2002-11-06
EP1254132A4 true EP1254132A4 (en) 2003-04-16

Family

ID=3819330

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01901059A Withdrawn EP1254132A4 (en) 2000-01-21 2001-01-22 Food product and process

Country Status (16)

Country Link
US (1) US20030157225A1 (en)
EP (1) EP1254132A4 (en)
JP (1) JP2003520794A (en)
CN (1) CN1227245C (en)
AU (1) AUPQ520300A0 (en)
BR (1) BR0107701A (en)
CA (1) CA2397565A1 (en)
HK (1) HK1053119A1 (en)
HU (1) HUP0203740A2 (en)
IL (2) IL150464A0 (en)
MX (1) MXPA02007070A (en)
NO (1) NO20023442D0 (en)
NZ (1) NZ531462A (en)
TR (1) TR200201829T2 (en)
WO (1) WO2001053285A1 (en)
ZA (1) ZA200205147B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40792E1 (en) * 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
WO1998050026A1 (en) * 1997-05-01 1998-11-12 Novogen Inc Treatment or prevention of menopausal symptoms and osteoporosis
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
US20040072814A1 (en) 2002-10-11 2004-04-15 Solvay Pharmaceuticals Gmbh Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds
CN1181742C (en) * 2003-03-03 2004-12-29 全英滨 Blood pressure and blood fat lowering herbal food
JP2005089396A (en) * 2003-09-19 2005-04-07 Pola Chem Ind Inc Isoflavone-containing oral administration composition
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
US7553505B2 (en) * 2006-01-12 2009-06-30 The Hong Kong University Of Science And Technology Health care product containing isoflavone aglycones and method of producing the same
KR101849059B1 (en) * 2008-12-11 2018-04-13 악센투아 파마슈투칼스 아베 Crystalline forms of genistein
US7863325B2 (en) * 2008-12-11 2011-01-04 Axcentua Pharmaceuticals Ab Crystalline genistein sodium salt dihydrate
CN107739358B (en) * 2017-09-21 2021-03-02 天津大学 Daidzein anhydrous crystal form II, preparation method and medical application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5247102A (en) * 1990-04-06 1993-09-21 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Process for the preparation of substituted isoflavone derivative
WO1996041800A1 (en) * 1995-06-12 1996-12-27 Chavunduka, Gordon, Lloyd Isolation of naturally occurring isoflavanone and some clinical uses thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518002C3 (en) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavans and isoflavens and processes for their production and medicinal products containing them
DE1543749A1 (en) * 1966-02-16 1969-12-11 Merck Ag E Process for the preparation of 3,4-cis-4-aryl-isoflavans
US3973608A (en) * 1973-08-01 1976-08-10 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Microbial production of certain isoflavones
DE2643800C2 (en) * 1976-09-29 1986-10-30 Fritz Werner Industrie-Ausrüstungen GmbH, 6222 Geisenheim Process for the production of xylose by the enzymatic hydrolysis of xylans
US4264509A (en) * 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4157984A (en) * 1977-06-08 1979-06-12 Z-L Limited Antioxidants, antioxidant compositions and methods of preparing and using same
SU907060A1 (en) * 1979-02-07 1982-02-23 Всесоюзный Научно-Исследовательский Биотехнический Институт Process for preparing rose oil
US4390559A (en) * 1979-04-11 1983-06-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4366082A (en) * 1979-04-11 1982-12-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
JPS5933232A (en) * 1982-08-19 1984-02-23 Tokiwa Kanpou Seiyaku:Kk Separation of saponin and flavone from leguminous plant
US4557927A (en) * 1983-03-10 1985-12-10 Kabushiki Kaisha Hoyashibara Food products and process for producing same
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
US5153230A (en) * 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
CH679584A5 (en) * 1989-11-10 1992-03-13 Nestle Sa
GB2261671B (en) * 1991-11-16 1996-07-03 Gb Biotech Gel production from plant matter
USRE40792E1 (en) * 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
CA2160371A1 (en) * 1993-04-16 1994-10-27 The Trustees Of Tufts College Method for treatment of menopausal and premenstrual symptoms
US5320949A (en) * 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
CA2173999C (en) * 1993-10-12 2008-09-09 Jerome L. Shen An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing
JP3777390B2 (en) * 1993-10-12 2006-05-24 アーチャー ダニエルズ ミッドランド カンパニー Aglucone isoflavone-enriched plant protein extract and isolate and method for producing the same
IL112061A (en) * 1994-01-13 1999-10-28 Bristol Myers Squibb Co Methods for the preparation of taxanes
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5424331A (en) * 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5547866A (en) * 1994-07-20 1996-08-20 The Regents Of The University Of California Taxane production in haploid-derived cell cultures
US5516528A (en) * 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US5523087A (en) * 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5679806A (en) * 1995-02-24 1997-10-21 Hauser, Inc. Process for the isolation and purification of isoflavones
JPH08283283A (en) * 1995-04-14 1996-10-29 Kikkoman Corp Malonylisoflavone glucoside and method for obtaining isoflavone glucoside or isoflavone aglycon from the same substance
US5639785A (en) * 1995-06-07 1997-06-17 Global Pharma, Ltd. Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
US5554519A (en) * 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5726034A (en) * 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
US5804234A (en) * 1996-09-13 1998-09-08 Suh; John D. Plant protein for nutritional products and method of making same
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
US6146668A (en) * 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
WO1998050026A1 (en) * 1997-05-01 1998-11-12 Novogen Inc Treatment or prevention of menopausal symptoms and osteoporosis
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5942539A (en) * 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
US6004558A (en) * 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
US6132795A (en) * 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
KR20010041935A (en) * 1998-03-16 2001-05-25 데이비드 엠 모이어 Compositions for regulating skin appearance
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
US20040072765A1 (en) * 1999-04-28 2004-04-15 Novogen Research Pty Ltd. Cardiovascular and bone treatment using isoflavones
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
AUPR363301A0 (en) * 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
US20050119301A1 (en) * 2001-03-16 2005-06-02 Alan Husband Treatment of restenosis
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5247102A (en) * 1990-04-06 1993-09-21 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Process for the preparation of substituted isoflavone derivative
WO1996041800A1 (en) * 1995-06-12 1996-12-27 Chavunduka, Gordon, Lloyd Isolation of naturally occurring isoflavanone and some clinical uses thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DIXON R A ET AL: "MOLECULAR CONTROLS FOR ISOFLAVONOID BIOSYNTHESIS IN RELATION TO PLANT AND HUMAN HEALTH", PHYTOCHEMICALS IN HUMAN HEALTH PROTECTION, NUTRITION AND PLANT DEFENSE, KLUWER ACADEMIC, NEW YORK, NY,, US, 1999, pages 133 - 159, XP000921431 *
DOMINGUEZ, E. ET AL.: "Synthesis, Crystal Structure Determination and Pharmacological Activity of 7,8,3',4'-Tetramethoxyisoflavone", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 28, 1991, pages 1885 - 1889, XP002231100 *
INGHAM J L: "ISOFLAVONOIDS FROM THE ROOT BARK OF PISCIDIA ERYTHRINA AND A NOTE ON THE STRUCTURE OF PISCIDONE", ZEITSCHRIFT FUER NATURFORSCHUNG. SECTION C. BIOSCIENCES, XX, XX, vol. 44C, 1989, pages 905 - 913, XP000577557, ISSN: 0341-0382 *
IQBAL CHOUDHARY, M. ET AL.: "Four new Flavones and a New Isoflavone from Iris bungei", JOURNAL OF NATURAL PRODUCTS, vol. 64, 2001, pages 857 - 860, XP002231099 *
See also references of WO0153285A1 *
SHIBUYA Y ET AL: "NEW ISOFLAVONE GLUCOSIDES FROM WHITE LUPIN (LUPINUS ALBUS L.)", ZEITSCHRIFT FUER NATURFORSCHUNG. SECTION C. BIOSCIENCES, XX, XX, vol. 46, no. 7/8, July 1991 (1991-07-01), pages 513 - 518, XP001122873, ISSN: 0341-0382 *
TANAKA, H. ET AL.: "Revised Structures for Senegalensin", JOURNAL OF NATURAL PRODUCTS, vol. 64, 2001, pages 1336 - 1340, XP002231098 *

Also Published As

Publication number Publication date
MXPA02007070A (en) 2003-04-14
HK1053119A1 (en) 2003-10-10
CA2397565A1 (en) 2001-07-26
WO2001053285A1 (en) 2001-07-26
CN1395574A (en) 2003-02-05
HUP0203740A2 (en) 2003-03-28
JP2003520794A (en) 2003-07-08
BR0107701A (en) 2002-10-15
NZ531462A (en) 2006-04-28
AUPQ520300A0 (en) 2000-02-17
EP1254132A1 (en) 2002-11-06
NO20023442L (en) 2002-07-17
ZA200205147B (en) 2003-06-26
NO20023442D0 (en) 2002-07-17
TR200201829T2 (en) 2002-11-21
CN1227245C (en) 2005-11-16
US20030157225A1 (en) 2003-08-21
IL150464A (en) 2007-07-04
IL150464A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
GB2383516B (en) Food product
HUP0202723A3 (en) Food product and process for manufacturing same
GR20010300063T1 (en) Meat product
EG23534A (en) Dairy product and process
GB2372509B (en) Beta-glucan process,additive and food product
GB0303716D0 (en) Food product and process
EP1465497A4 (en) Dairy product and process
PT1296561E (en) Fermented milk product and process
GB9927474D0 (en) Food product
GB0119068D0 (en) Shellfish product and process
HK1053119A1 (en) Food product and process
HUP0202304A3 (en) Food product
MXPA01002408A (en) Granola-type food product and method of production thereof.
GB0012938D0 (en) Edible products
IL137470A0 (en) Nutritional food product and process for its preparation
AU144947S (en) Bread product
AU144948S (en) Bread product
GB0013685D0 (en) Snack food product
AU2002217858A1 (en) Container forming method and product
GB0006276D0 (en) A convenience food product and method of making the same
GB0112640D0 (en) Process and product
AU2002356472A8 (en) Dairy process and product
HU0002421D0 (en) Puffed food product and method for making the same
GB0021630D0 (en) Food product
HU9901032D0 (en) Food koncentrate and process for producing

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020709

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030304

17Q First examination report despatched

Effective date: 20030527

17Q First examination report despatched

Effective date: 20030527

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: METHOD FOR RECOVERING CRYSTALLINE ISOFLAVONES

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080411